Cargando…
ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells
Despite all the blood-based biomarkers used to monitor prostate cancer patients, prostate cancer remains as the second common cause of cancer mortality in men in the United States. This is largely due to a lack of understanding of the molecular pathways that are responsible for the aggressive forms...
Autores principales: | Tome-Garcia, Jessica, Li, Dan, Ghazaryan, Seda, Shu, Limin, Wu, Lizhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061020/ https://www.ncbi.nlm.nih.gov/pubmed/24937171 http://dx.doi.org/10.1371/journal.pone.0099525 |
Ejemplares similares
-
Functional analysis implicating the SNP rs61552325 in ERBB2 as an effector for androgen-insensitive prostate cancer cell invasion
por: Xin, Xianxiang, et al.
Publicado: (2017) -
The challenges of androgen insensitivity syndrome
por: Ovidiu, Bratu, et al.
Publicado: (2021) -
Integrin Involvement in Freeze Resistance of Androgen-Insensitive Prostate Cancer
por: Baust, John G., et al.
Publicado: (2010) -
A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells
por: Li, Tzu-Huey, et al.
Publicado: (2007) -
Potential risk of inguinal hernia in complete androgen insensitivity
syndrome
por: Kimizuka, Yu, et al.
Publicado: (2022)